News
-
-
-
PRESS RELEASE
Medios expects further growth in revenue and earnings after record year 2024
Medios expects further growth in revenue and earnings after a record year in 2024. Consolidated revenue up 5.5% to €1.9 billion. EBITDA pre1 margin reaches 4.2%. Positive outlook for 2025 with revenue expected to reach €2.0 billion -
-
PRESS RELEASE
Full-year 2024 results: improved profitability and strong cash generation in the second half
Exail Technologies excels in 2024 with strong financial performance, record order intake, revenue growth, EBITDA improvement, and debt reduction. Strategic success in defense sector. Perspectives focus on drone systems and defense markets -
-
PRESS RELEASE
Steyr Motors AG is considering initial acquisitions to further develop its expansion and profitability alongside strong global organic growth
Steyr Motors AG plans initial acquisitions to boost expansion and profitability amid strong organic growth. The Austrian company targets European and Asian markets for new acquisitions -
PRESS RELEASE
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market -
PRESS RELEASE
Baloise delivers an operationally successful year and increases its dividend
Baloise Holding AG reports operationally successful year with improved core business, increased dividend, and strong cash remittance of CHF 565 million. Annual results show improved combined ratio and higher return on equity -
PRESS RELEASE
Medacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0%
Medacta Group SA reports excellent 2024 performance with 28.0% adjusted EBITDA margin. Revenue up 16.2% in constant currency. Board proposes CHF 0.69 per share distribution. Outlook targets 13-15% revenue growth & 27% EBITDA margin for 2025
